Industry News

GSK and Amicus Therapeutics revise Fabry agreement entered into in July 2012.

Stada licenses 3M's transdermal technology for a fentanyl patch.

Coldstream Laboratories names director of formulation development.

Camargo Pharmaceuticals appoints a veteran health executive as new COO.

CareFusion will acquire GE Healthcare’s Vital Signs division.

Unilife to begin commercial supply in 2014.

Catalent has signed a product development agreement with immunology company Pure MHC (major histocompatibility complex), which specializes in MHC-based diagnostics and therapeutics.

Xcelience appoints Clinical Supplies VP of its new Birmingham, United Kingdom site.

USP issues call for candidates for its 2015-2020 Council of Experts.

Covance Inc. and Pathoquest have announced a collaboration to provide next-generation sequencing (NGS) based biosafety assessments to detect and identify viral contaminants within biologic compounds.

The systems are designed for the manufacture of oncology products and to research new biotech products.

Lyra Myers, associate director and value creation agent at Roche, has been elected DCAT president.

Merck Millipore has introduced a new solubility/bioavailability enhancement excipient, Parteck SLC, which has a unique pore structure that enables higher loading of amorphous APIs, thereby, improving dissolution rates and increasing drug solubility.

Pfenex receives subcontract from Leidos to develop a production process for the malaria antigen Plasmodium falciparum reticulocyte-binding homolog 5 (Rh5).

DSM Pharmaceuticals appoints a new business unit director of its DSM Biologics/BioSolutions businesses.

Bend Research adds powder-filling technology.

Novasep?s European manufacturing sites in France and Germany pass FDA audits.

Repligen completes expansion of its manufacturing facilities at its Massachusetts headquarters.

DSM Pharmaceutical signs manufacturing agreements with Opthea and Sanquin.

WuXi PharmaTech completed a general GMP and pre-approval inspection from FDA.

Cambridge Major Laboratories and AAIPharma Services appoints Patrick D. Walsh as CEO of merged company.

Clariant opens its new Clariant Innovation Center in Germany, a hub for R&D research.

Dow Chemical and Cambrex open a new facility for Dow?s hydroxypropyl methylcellulose acetate succinate (HPMCAS).

WuXi PharmaTech has completed a cell culture capacity expansion, including two 2000 L disposable bioreactors.

Novartis files Citizen Petition with FDA to maintain naming policy for all biologics to help ensure patient safety.

Combined service offers drug development companies efficiencies in time and resource.

Cobra Biologics installs a new single-use bioreactor to expand its antibody GMP production capacity.

Thomas Engineering names David Decker as the new director of European operations.

ISPE will discuss FDA’s recent draft guidance on breakthrough therapies at its 2013 Annual Meeting.

PharmaCell will become the European CMO for Dendreon for the commercial production of its cellular immunotherapy product Provenge.